Menu

Medication Safety

Medication Safety

Too many patients are re-hospitalized for adverse drug events

Partnering with organizations in Arkansas, Missouri, Oklahoma, Puerto Rico and Texas, TMF Health Quality Institute aims to reduce adverse drug events by 35 percent by 2019 and reduce unnecessary hospital admissions and readmissions associated with three drug categories, anticoagulants, diabetic and opioid agents, by 1 percent for the five-state region by 2019 . By facilitating the Medication Safety Learning and Action Network, TMF is leading the effort to meet this goal.

Funded by the Centers for Medicare & Medicaid Services, this "all participate, all learn" Medication Safety Learning and Action Network seeks to connect all comers in communities of directed learning that will successfully reduce adverse drug events and promote medication safety practices. Participants include hospitals, skilled nursing facilities, home health agencies, inpatient rehabilitation facilities, long-term acute care hospitals, pharmacies, pharmacists, physicians and other clinicians along with stakeholders, patients and other motivated individuals.

A big problem with a community solution

Frequent adverse drug events and hospital readmissions are not just a patient and hospital problem; they are a community problem with all providers in the community having a role in achieving the high quality, coordinated and patient-centered care that prevents avoidable readmissions and reduces adverse drug events for the patients we all serve.

We know simply raising broad awareness of better practice will not achieve sustainable results, nor will it change behaviors on a large scale. However, a Learning and Action Network of peers and communities willing to share, interact, ask, integrate and implement creates a forceful momentum for change.

We encourage you to join this important endeavor to achieve sustainable and measurable results in reducing adverse drug events and unnecessary admissions associated with anticoagulants, diabetic and opioid agents.